KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;

@FiercePharma: Study finds Revlimid's interaction w/Pgp affects blood levels, so dosing might need tweaks. | Follow @FiercePharma

> KV Pharmaceutical wrapped up the $60 million sale of its generics unit to Zydus Pharmaceuticals and Zynesher Pharmaceuticals. Report

> Contract manufacturer Aenova plans to lease a SkyePharma manufacturing business near Lyon, France. News

> Hungary's Gedeon Richter said Genefar had been ordered to pay it $40 million for breach of contract in a dispute over the failed buyout of Polpharma. Story

> Gastrointestinal specialist Salix Pharmaceuticals saw its second-quarter profit beat analyst estimates on growing sales of its diarrhea drug Xifaxan. Item

> Endo Pharmaceuticals raised its forecast for sales and earnings as it reported Q2 income of $54.6 million on $607 million in sales. Article

> A start-up has released a software tool to help pharmaceutical companies track comments on Facebook, now that the social media site is enabling two-way communication on drugmakers' pages. Release

> Pfizer and AstraZeneca filed separate patent suits against India's Hetero Drugs, one involving a Viagra copycat and the other concerning a generic version of Nexium. Story

> Bachem said it had renewed a longstanding agreement with AstraZeneca to supply the drug Goserelin. Report

> A Maryland oncologist pleaded guilty to using a misbranded drug after administering cancer meds bought outside the U.S. Piece

Biotech News

@FierceBiotech: Is the FDA writing a recipe for the failure of biosimilars in the U.S.? Report | Follow @FierceBiotech  

@JohnCFierce: So Lexicon says its Ph2 study for LX1032 showed signs of efficacy, reducing symptoms of gastro-related tumors. | Follow @JohnCFierce

@MaureenFierce: Several Russian cos. have establish a $ joint venture designed to develop innovative treatments in the country. | Follow @MaureenFierce

> Biogen, Abbott tout promising MS data from PhIIb daclizumab deal. Story

> Array adds $713M cancer drug pact with Genentech to deal roster. Report

Biotech Research News

> Gene discovered that regulates the timing of our tickers. News

> DoD gives NeoStem $1.7M to develop adult stem cells for osteoporosis. More

> Scientists discover possible genetic route to killing pain. Details

> Standford's SPARK hosts ideas so "crazy" they just might work. Story

> Researcher find faulty gene responsible for some ovarian cancers. Report

> Texas Gov. Perry supports adult stem cells after undergoing procedure. Article

Manufacturing News

> At the box office, bad boy pharma on top. Details

> UPS sees new tech, distribution models for supply chain. Story

> Roche deals API plants in SC, CO. Article

> Merck pushes pharma to top jobs-cutter. More

> NSF expands into chemical reference standards. Report

And Finally... Soy tablets do little to stave off bone loss among menopausal women, according to new research, and don't help with hot flashes, either. Report

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.